A Team-Based Approach to Combatting the Opioid Epidemic: Roles for Pharmacists

Size: px
Start display at page:

Download "A Team-Based Approach to Combatting the Opioid Epidemic: Roles for Pharmacists"

Transcription

1 A Team-Based Approach to Combatting the Opioid Epidemic: Roles for Pharmacists Elise A. Dasinger, PharmD, MHA Fellow, VA Quality Scholars Program Birmingham VA Medical Center & The University of Alabama at Birmingham

2 Disclosure & Disclaimer Statements Disclosure: I have no actual or potential conflict of interest in relation to this presentation. Disclaimer: The views expressed in this presentation are those of the presenter and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States Government. 2

3 3

4 Pharmacists Can Help HOSPITAL EDUCATION COMMUNITY 4

5 PROVIDING EDUCATION 5

6 VA s Success with Pharmacist-Led Education Academic Detailing: A service-oriented outreach education for health care professionals by health care professionals; leveraging the one-on-one communication approach of pharmaceutical industry detailers combined with the evidence-based, noncommercial aims of academic groups, research, and development centers. Provides access to balanced evidence-based information in an effective and impactful way Quality-oriented approach that helps providers make appropriate clinical decisions, ideally based on the best available safety, efficacy, and costeffectiveness data Provider Patient Academic Detailing Admin; Leaders 6

7 Opioid Use Disorder Pain Specific Provider Resources Materials Educational Moving Materials Beyond Opioids A VA Clinician s Guide (2017) VANational Academic Detailing Service S.T.O.P. P.A.I.N. Educational Materials Pain/Opioid Safety Initiative Pain/Opioid Safety Initiative Transforming the Treatment of Chro Pain/Opioid Safety Initiat Headache Provider Materials Transforming the Treatment of Chronic P Acute Pain Management Moving Beyond Opioids Opioid Safety A VA Clinician s Guide (2017) Opioid Use Dis VA Educational Guide (2017) Opioid Use Disorder Provider Materials A Suicide VA Clinician and P of Opioid Use D Provider Materials Opioid Use Disorder Transforming the Treatment of Pain A Quick Reference Guide (2017) Transforming the Treatment Opioid of Pain Use Dis A Quick Reference Guide Identification (2017) Opioid Medica Transforming Acute Pain the Treatment of Chronic Pain Do You Know Moving Opioids Beyond Are Not Always Opioids the Answer A VA Clinician s Guide (2017) Opioid Use Disorder Opioid Taper Decision Tool H Identification and Management of Opioid Use Disorde S Opioid Taper Decision Tool Patient Materials Opioid Use Opioid Use Disorder A VA Clinician s Guide to Identification and Managem of Opioid Use Disorder (2016) H S VA Academic Detailing Service Educational Material Catalog STOP PAIN Materials Patient Materials Fentanyl & Carfentanil 7

8 Academic Detailing : Impact on Veterans > 100 MEDD Positive Impact? YES! 8

9 EMERGENCY DEPARTMENT PRESCRIBING Education: Acute Pain Campaign Identify Resources Aligning Practice with Guidelines Leadership Support Identify Barriers 9

10 Leadership Support Meet with facility leadership Assess baseline culture/feasibility of a new practice Identify a champion from the emergency department to drive project Engage key staff Review possible facility barriers from the perspective of leadership Leverage leadership to raise awareness of missing resource elements 10

11 Identify Resources Non-pharmacologic therapies & non-opioid pharmacotherapy Can ED providers directly consult specialists or refer to outside resources? Are there local restrictions on formulary products? Pain Dashboards (QI Measures) # of patients prescribed opioids in the ED New starts on long acting opioids Duration of the opioid prescription (> 5 days) New opioid prescriptions in patients on benzodiazepines New benzodiazepine prescription in patients on chronic opioids Operational Clinical Quality Improvement Opioid Measures (Appendix B) in CDC Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain 11

12 Identify Barriers Emergency Department Providers Ability to order non-opioid therapies Ensuring the ED provider has time to review alternatives to opioids Challenge of managing the demands of patients in the ED expecting opioid prescriptions Differences in prescribing between full time providers compared to contracted providers 12

13 Aligning Practice with Guidelines Determine which guideline recommendations to implement Prioritize what will be implemented Repeat visits to measure willingness to commit to behavior change and adopt new practice Follow-up with priority providers Monitor progress using QI measures and other data Highlight successes, share stories that change lives! 13

14 HOSPITAL SETTING Pharmacist-Led Opioid Exit Plan (OEP) 14

15 Pharmacist-Led Opioid Exit Plan (OEP) Pharmacists guide appropriate therapeutic selection of opioids for pain management Strength and quantity written on discharge Staffing Trained staff pharmacist or clinical pain management pharmacist Student pharmacist(s) for discharge counseling Time Commitment Interdisciplinary rounds: min/day Personalized postop pain management plan: min/patient Discharge counseling: 1-4 hours per day Follow-up: 2 days/week up to 3-4 hours/day Genord C, Frost T, Eid D. Opioid exit plan: A pharmacist's role in managing acute postoperative pain. J Am Pharm Assoc (2003). 2017;57(2S):S92-S98. 15

16 COMMUNITY SETTING Corresponding Responsibility The responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription. 21 CFR

17 Pharmacists in the Community Pharmacists are frequently mentioned in opioid risk reduction activities Educate patients Support safe medication storage and disposal Distribute naloxone (Ala. Code ) Last Defense against high-risk medication use Opioid Rx Limits at the Pharmacy Counter State: None Insurance: Ex. BCBS acute fill Company: Ex. Walmart acute fill Barriers for Community Pharmacists Workflow processes ( and time) Prescriber-pharmacist-patient communication PharmacistRespond.org 17

18 Drug Take Back Day October 27, :00 AM to 2:00 PM Posters available on website Locations available on website 18

19 Additional Recommended Opioid Resources CDC Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain Evidence-Based Strategies for Preventing Opioid Overdose: What s Working in the United States VHA Pain Management Opioid Safety Clinical Tools Resources Encouraging Safe Prescription Opioid & Naloxone Dispensing PharmacistRespond.org Michigan Opioid Prescribing Engagement Network 19

Veterans Health Administration Pharmacy Benefits Management Academic Detailing Services

Veterans Health Administration Pharmacy Benefits Management Academic Detailing Services Veterans Health Administration Pharmacy Benefits Management Academic Detailing Services Melissa Christopher, Pharm.D. National Director, Academic Detailing Services VACO PBM San Diego, California USA Academic

More information

Opioid Safety Initiative. Thomas Emmendorfer, PharmD Deputy Chief Consultant Pharmacy Benefits Management (PBM) Services

Opioid Safety Initiative. Thomas Emmendorfer, PharmD Deputy Chief Consultant Pharmacy Benefits Management (PBM) Services Opioid Safety Initiative Thomas Emmendorfer, PharmD Deputy Chief Consultant Pharmacy Benefits Management (PBM) Services 1 2 Opioid Safety Initiative (OSI) Overdose Education and Naloxone Distribution (OEND):

More information

Opioid epidemic and PEHP

Opioid epidemic and PEHP Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe

More information

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite

More information

Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative

Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative Objectives Summarize the current crisis at the national and Iowa state level.

More information

is rarely visible, and communication about use of opioids for chronic pain patients is ad hoc and informal.

is rarely visible, and communication about use of opioids for chronic pain patients is ad hoc and informal. Six Building Blocks Self-Assessment The purpose of the self-assessment is to initiate a discussion among the opioid improvement team (or all members of your clinic) about the current state of your organization

More information

It Takes A Village to Curb the Prescription Opioid Epidemic: Supply healthcare providers with resources to improve patient safety

It Takes A Village to Curb the Prescription Opioid Epidemic: Supply healthcare providers with resources to improve patient safety Session L6 This presenter has nothing to disclose It Takes A Village to Curb the Prescription Opioid Epidemic: CDC Efforts Jan Losby, PhD Team Lead, Overdose Prevention Health Systems Team Division of

More information

Opioid Overdose Education and Naloxone Distribution

Opioid Overdose Education and Naloxone Distribution Opioid Overdose Education and Naloxone Distribution Emily Stoukides, PharmD PGY-2 Ambulatory Care Pharmacy Resident Nicole Brunet, PharmD, BCPP Clinical Pharmacy Specialist, Mental Health Disclosures Emily

More information

Potential Solutions to Epidemic Substance Abuse in US and Europe

Potential Solutions to Epidemic Substance Abuse in US and Europe Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine

More information

6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES

6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES First Do No Harm Implementing an Opioid Stewardship Program in a HealthCare System Phil Chang, MD Kristy Deep, MD Doug Oyler, PharmD June 12, 2017 OBJECTIVES Explain the role of opioid stewardship as a

More information

Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration

Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration Evaluation of National Academic Detailing Service on Naloxone Kit Prescription Rates in the Veterans Health Administration Melissa LD Christopher, PharmD National Director Academic Detailing Program Office

More information

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able

More information

Prescription Opioid Overdose in Oregon: A public health perspective

Prescription Opioid Overdose in Oregon: A public health perspective Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,

More information

CDC Guideline for Prescribing Opioids for Chronic Pain

CDC Guideline for Prescribing Opioids for Chronic Pain National Center for Injury Prevention and Control CDC Guideline for Prescribing Opioids for Chronic Pain John Halpin, MD, MPH Medical Officer Division of Unintentional Injury Prevention Prescription Drug

More information

Naloxone and Combating the Opioid Epidemic

Naloxone and Combating the Opioid Epidemic Objectives Naloxone and Combating the Opioid Epidemic Jeff Jacobson PharmD Southpointe Pharmacy Discuss the current opioid crisis Define the role of Naloxone in opioid overdose Analyze the barriers to

More information

Addressing the Opioid Epidemic in the Veterans Health Administration

Addressing the Opioid Epidemic in the Veterans Health Administration Addressing the Opioid Epidemic in the Veterans Health Administration Julie Gochnour, MD Governor s Working Group on Veterans, Service Members, and Their Families May 25, 2017 Overview Epidemiology of the

More information

Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review

Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review 1 Initiative #1: Aiming for Equity in Sexual Violence Prevention - Mapping Risks, Policies, Outcomes and Resources Statement

More information

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

Implementing Pain and Opioid Management Guidelines in Primary Care Practice Implementing Pain and Opioid Management Guidelines in Primary Care Practice Objectives 1. What is the issue? 2. Why use a dedicated dissemination & implementation process? a. Historical perspective Cooperative

More information

TN Opioid Program. Erica Schlesinger, Pharm.D

TN Opioid Program. Erica Schlesinger, Pharm.D TN Opioid Program Erica Schlesinger, Pharm.D Nothing to disclose Disclosures TN Together Governor Haslam s Plan Prevention Establishes limits, decreases supply and dosage of prescription opioids Limits

More information

Disclosures 6/5/2017. Dr. Franklin has no disclosures Dr. Ngo has no disclosures

Disclosures 6/5/2017. Dr. Franklin has no disclosures Dr. Ngo has no disclosures Tu Ngo, PhD, MPH Julie Franklin, MD, MPH International Conference on Opioids Boston, MA June 11, 2017 1 Disclosures Dr. Franklin has no disclosures Dr. Ngo has no disclosures 2 Objectives Identify areas

More information

ADDRESSING THE OPIOID CRISIS:

ADDRESSING THE OPIOID CRISIS: ADDRESSING THE OPIOID CRISIS: Preventing Abuse and Ensuring Patients Receive the Right Care in the Right Setting September 2018 EXECUTIVE SUMMARY Every day, about 115 Americans die from opioid abuse. 1

More information

Safina Koreishi, MD, MPH, Medical Director, Columbia Pacific CCO

Safina Koreishi, MD, MPH, Medical Director, Columbia Pacific CCO Using Leadership to Change Practice: A CPCCO s Journey towards Addressing the Opioid Epidemic Oregon Conference on Opioids, Pain and Addiction Treatment, May 19, 2018 Safina Koreishi, MD, MPH, Medical

More information

Aligning Market Objectives and Policy for National Public Health

Aligning Market Objectives and Policy for National Public Health Abuse-Deterrent Formulations Summit March 7, 2017 Alexandria, Virginia Aligning Market Objectives and Policy for National Public Health Shruti Kulkarni, Esq. Outside Counsel Twitter: @claad_coalition CLAAD

More information

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals Clint Ross, PharmD, BCPP Clinical Pharmacy Specialist Psychiatry Residency Program Director Psychiatric Pharmacy Medical University

More information

2018 Opioid Initiative Wave I - Benchmarking Guide

2018 Opioid Initiative Wave I - Benchmarking Guide 2018 Opioid Initiative Wave I - Benchmarking Guide Disclosures & Disclaimer Presenter Centers for Medicare and Medicaid Innovation: ACEP TCPI Contracted with Centers for Medicare and Medicaid Services

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

Opioid Management of Chronic (Non- Cancer) Pain

Opioid Management of Chronic (Non- Cancer) Pain Optima Health Opioid Management of Chronic (Non- Cancer) Pain Guideline History Original Approve Date 5/08 Review/Revise Dates 11/09, 9/11, 9/13, 09/15, 9/17 Next Review Date 9/19 These Guidelines are

More information

A Systems Approach to the Opioid Crisis Safina Koreishi, MD, MPH Mara Laderman, MSPH Lindsay Martin, MSPH

A Systems Approach to the Opioid Crisis Safina Koreishi, MD, MPH Mara Laderman, MSPH Lindsay Martin, MSPH A26/B26 These presenters have nothing to disclose A Systems Approach to the Opioid Crisis Safina Koreishi, MD, MPH Mara Laderman, MSPH Lindsay Martin, MSPH December 6, 2016 9:30 10:45 AM 11:15 AM 12:30

More information

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017 Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic October 25, 2017 Disclosures and Disclaimer Neither the Institute for Health Policy and Leadership (IHPL) nor I have any relevant financial

More information

WORKING UPSTREAM TO COMBAT THE OPIOID CRISIS

WORKING UPSTREAM TO COMBAT THE OPIOID CRISIS WORKING UPSTREAM TO COMBAT THE OPIOID CRISIS WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association PRESENTER Sarah Derr, PharmD Medication Management Lead Iowa Healthcare

More information

Recommendations for Components of Emergency Department Discharge Protocols

Recommendations for Components of Emergency Department Discharge Protocols Recommendations for Components of Emergency Department Discharge Protocols Background Maryland, like many other states, is in the midst of an opioid crisis. In 2016, 89 percent of all intoxication deaths

More information

PDMP Tools to Identify Red Flag Situations

PDMP Tools to Identify Red Flag Situations PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management

More information

TITLE AUTHORS. Lucas G. Hill, PharmD The University of Texas at Austin College of Pharmacy

TITLE AUTHORS. Lucas G. Hill, PharmD The University of Texas at Austin College of Pharmacy TITLE Naloxone Counseling for Harm Reduction and Patient Engagement AUTHORS Lucas G. Hill, PharmD The University of Texas at Austin College of Pharmacy Marianne E. Koenig, PharmD UPMC St. Margaret Family

More information

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 The STOP Measure Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018 AHIP s Safe, Transparent Opioid Prescribing (STOP) Initiative Methodology

More information

Alamance County Leadership Forum Follow-up Report

Alamance County Leadership Forum Follow-up Report Alamance County Leadership Forum Follow-up Report On December 8, 2017, a County Leadership Forum on Opioid Abuse was held in Alamance County. Established by the North Carolina Association of County Commissioners,

More information

CDC s Approach to Addressing the Opioid Overdose Epidemic

CDC s Approach to Addressing the Opioid Overdose Epidemic CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths

More information

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE Sean Court Director, Strategic Policy Branch Ministry of Health and Long-Term Care November 24, 2017 Strategy to Prevent Opioid Addiction and

More information

Oregon Opioid Overdose Prevention Initiative

Oregon Opioid Overdose Prevention Initiative Oregon Opioid Overdose Prevention Initiative Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Association of Hospitals & Health Systems February 2017

More information

Prescription Drug Abuse National Perspective

Prescription Drug Abuse National Perspective Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs

More information

Opioid Overdose in Oregon: A Public Health Perspective Mary Borges PDO Coordinator Drew Simpson PDMP Coordinator Oregon Public Health Division

Opioid Overdose in Oregon: A Public Health Perspective Mary Borges PDO Coordinator Drew Simpson PDMP Coordinator Oregon Public Health Division Opioid Overdose in Oregon: A Public Health Perspective Mary Borges PDO Coordinator Drew Simpson PDMP Coordinator Oregon Public Health Division Mid-Willamette Valley Pain Conference Sept 2017 Objectives

More information

Changing Course: statewide efforts to combat the opioid epidemic in California

Changing Course: statewide efforts to combat the opioid epidemic in California Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries

More information

Addressing Challenges Together, One Rock at a Time

Addressing Challenges Together, One Rock at a Time Addressing Challenges Together, One Rock at a Time PAMELA SCHWEITZER, PHARM.D., BCACP ASSISTANT SURGEON GENERAL REAR ADMIRAL (RADM), U.S. PUBLIC HEALTH SERVICE E-MAIL: PAMELA.SCHWEITZER@CMS.HHS.GOV @USPHSPHARMACY

More information

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of amphetamines and opioids, both prescription and illicit, among

More information

Overcoming the Substance Abuse Epidemic: One Member at a Time

Overcoming the Substance Abuse Epidemic: One Member at a Time Overcoming the Substance Abuse Epidemic: One Member at a Time Innovation and Partnerships: our keys to success Sosunmolu Shoyinka, M.D., FAPA Medical Director for Substance Use Disorders, Centene Corporation.

More information

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service Suicide Prevention: From a Pharmacist s Perspective Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service CPE Information and Disclosures Daina L. Wells declare(s) no conflicts of interest,

More information

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System Session L6 This presenter has nothing to disclose It Takes a Village to Curb the Prescription Opioid Epidemic: Reducing Opioid Over- Prescribing in a Large Integrated Health Care System Joel D. Hyatt,

More information

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

On December 27, 2017, the Lieutenant Governor signed into law several new requirements OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

ScO.S. Academic Detailing for Safer Prescribing

ScO.S. Academic Detailing for Safer Prescribing ScO.S. Academic Detailing for Safer Prescribing Sarah Ball, PharmD Research Assistant Professor MUSC College of Medicine September 6, 2017 Megan Pruitt, PharmD SCORxE Clinical Pharmacy Consultant MUSC

More information

Presentation Objectives

Presentation Objectives Oregon s PDMP 101 Lisa Millet, MSH, Section Manager Injury and Violence Prevention Section Center for Prevention and Health Promotion Oregon Health Authority Eugene Oregon PDO Summit April 20, 2016 1 Presentation

More information

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services: Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata

More information

Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program

Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Illinois Prescription Monitoring Program Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Agenda Provide an overview of the Illinois Prescription Monitoring Program

More information

STATEMENT FOR THE RECORD. Submitted to the. Senate Committee on Health, Education, Labor, & Pensions

STATEMENT FOR THE RECORD. Submitted to the. Senate Committee on Health, Education, Labor, & Pensions STATEMENT FOR THE RECORD Submitted to the Senate Committee on Health, Education, Labor, & Pensions The Opioid Crisis: The Role of Technology and Data in Preventing and Treating Addiction February 27, 2018

More information

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical

More information

Prescription Opioid Policies (22 March 2016)

Prescription Opioid Policies (22 March 2016) Prescription Opioid Policies (22 March 2016) Prescription opioid misuse and abuse has become problematic in the United States and internationally in economically developed countries. Increased use of opioids

More information

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation. Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education

More information

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit Revised 9/30/2016 Primary Care Provider Pain Management Toolkit TABLE OF CONTENTS 1. INTRODUCTION Page 1 2. NON-OPIOID SERVICES &TREATMENTS FOR CHRONIC PAIN Page 2 2.1 Medical Services Page 2 2.2 Behavioral

More information

Defense Health Agency PROCEDURAL INSTRUCTION

Defense Health Agency PROCEDURAL INSTRUCTION Defense Health Agency PROCEDURAL INSTRUCTION NUMBER 6025.04 DHA/Healthcare Operations SUBJECT: Pain Management and Opioid Safety in the Military Health System (MHS) References: See Enclosure 1. 1. BACKGROUND.

More information

2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS)

2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS) 2017 PGIP Fact Sheet Electronic Prescribing of Controlled Substances (EPCS) Overview Value Partnerships, in conjunction with the Blue Cross Pharmacy team, has created the Electronic Prescribing of Controlled

More information

CSS Perspective - Opioid Risk Management

CSS Perspective - Opioid Risk Management Tufts Health Care Institute Program on Opioid Risk Management Risk Evaluation and Mitigation Strategy for Prescription Opioids: An In-Depth Review of Fundamental Issues CSS Perspective - Opioid Risk Management

More information

Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention

Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention The people of Cardinal Health care deeply about the devastation opioid abuse has caused American families and communities

More information

Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices

Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices Opioid Safety: Prescribing Guidelines, Quality Measures and Care Coordination Best-Practices August 25, 2017 Presented by Michael Crooks, PharmD. Medication Safety and Care Coordination Task Lead 8/28/2017

More information

Idaho DUR Board Meeting Minutes. Committee Member Present: David Agler, M.D., Dawn Berheim, Pharm.D., Perry Brown, M.D., Matthew Hyde, Pharm.D.

Idaho DUR Board Meeting Minutes. Committee Member Present: David Agler, M.D., Dawn Berheim, Pharm.D., Perry Brown, M.D., Matthew Hyde, Pharm.D. Idaho DUR Board Meeting Minutes Date: January 25, 2018 Time: 9am-12:00pm Location: Idaho Medicaid, 3232 Elder Street, Boise, Idaho, Conference Room D-West Moderator: David Agler, M.D. Committee Member

More information

STARTER PACK: Webinar #1 ADE4 - OPIOIDS

STARTER PACK: Webinar #1 ADE4 - OPIOIDS STARTER PACK: Webinar #1 ADE4 - OPIOIDS Welcome to the Starter Pack Webinar #1 Why this is important Establishing a Team Best practices Understanding the Measures Completing a gap analysis First Steps

More information

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:

More information

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016)

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016) What do we mean by the opioid crisis? 83 Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016) 675,315,375 Opioid pills dispensed in North Carolina in 2016 SOURCE:

More information

Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition. Matt Willis, MD MPH Public Health Officer Marin County

Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition. Matt Willis, MD MPH Public Health Officer Marin County Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition Matt Willis, MD MPH Public Health Officer Marin County What can we do as a community to prevent prescription drug misuse

More information

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Fraud and Compliance Forum, October 2017. Click here to access audio. AHLA X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion Michelle Bergholz Frazier Senior Vice President,

More information

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS Gina M. Raimondo, Governor Nicole Alexander-Scott, MD, MPH, Director of Health Action Plan Strategies to Date Since 2015, we

More information

July 6, Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration New Hampshire Avenue Silver Spring, MD 20993

July 6, Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration New Hampshire Avenue Silver Spring, MD 20993 Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 RE: Draft Revisions to the Food and Drug Administration Blueprint for Prescriber Education

More information

Community Engagement to Address the Opioid Crisis. Laura Palombi, PharmD, MPH, MAT, AE-C

Community Engagement to Address the Opioid Crisis. Laura Palombi, PharmD, MPH, MAT, AE-C Community Engagement to Address the Opioid Crisis Laura Palombi, PharmD, MPH, MAT, AE-C Presenter Information Assistant Professor at the University of Minnesota College of Pharmacy Affiliate Assistant

More information

Risk Classification Modeling to Combat Opioid Abuse

Risk Classification Modeling to Combat Opioid Abuse Risk Classification Modeling to Combat Opioid Abuse Improve Data Sharing to Identify High-Risk Prescribers of Opioids Christopher Sterling Chief Statistician NCI, Inc. www.nciinc.com 11730 Plaza America

More information

Welcome - we will begin the webinar shortly Please read the participation tips below:

Welcome - we will begin the webinar shortly Please read the participation tips below: Welcome - we will begin the webinar shortly Please read the participation tips below: All guest phones have been muted: Background noises, conversations, white noise etc., can be disruptive to a webinar.

More information

Michigan Opioid Legislation Hospital Compliance Checklist

Michigan Opioid Legislation Hospital Compliance Checklist MHA KEYSTONE CENTER MICHIGAN OPIOID LEGISLATION HOSPITAL COMPLIANCE CHECKLIST The Michigan Opioid Legislation was created by the Michigan Health & Hospital Association to help guide its member hospitals

More information

3. Has the patient had a sustained improvement in Pain or Function (e.g. PEG scale with a 30 percent response from baseline)?

3. Has the patient had a sustained improvement in Pain or Function (e.g. PEG scale with a 30 percent response from baseline)? Pharmacy Prior Authorization AETA BETTER HEALTH KETUCK Opioids Long-Acting and Short-Acting (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review

More information

Current IHI Efforts Addressing the Opioid Epidemic

Current IHI Efforts Addressing the Opioid Epidemic Current IHI Efforts Addressing the Opioid Epidemic Mara Laderman, Allison Perry, Matthew Jensen Wednesday, December 12 th, 2018 7:00am #IHIFORUM Session Objectives Understand IHI s efforts to address the

More information

Prepublication Requirements

Prepublication Requirements Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals

More information

Opioid Overdose in Oregon

Opioid Overdose in Oregon Opioid Overdose in Oregon Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Website: healthoregon.org/opioids 1 Prescription Opioids in Oregon: Oregon and prescription

More information

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce STATEMENT of the American Medical Association for the Record House Committee on Energy and Commerce RE: Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives October

More information

Six Building Blocks Self-Assessment Questionnaire Workshop Version July 2017

Six Building Blocks Self-Assessment Questionnaire Workshop Version July 2017 July 2017 Background The Six Building Blocks were developed as part of a research project on Team Based Opioid Management in rural clinics. The three year research study is a collaboration between 20 rural

More information

Impact of Opioid Prescribing Rules in Post Acute and Long Term Care

Impact of Opioid Prescribing Rules in Post Acute and Long Term Care Impact of Opioid Prescribing Rules in Post Acute and Long Term Care Jessica Van Fleet-Green, MD, FAAFP, CMD Chief Medical Officer, Physicians of Southwest Washington Medical Director, ManorCare Lacey History

More information

Cynthia B. Jones, Director Department of Medical Assistance Services (DMAS)

Cynthia B. Jones, Director Department of Medical Assistance Services (DMAS) Department of Medical Assistance Services 600 East Broad Street, Suite 1300 Richmond, Virginia 23219 MEDICAID MEMO http://www.dmas.state.va.us TO: All Prescribing Providers, Pharmacists, and Managed Care

More information

New Guidelines for Prescribing Opioids

New Guidelines for Prescribing Opioids New Guidelines for Prescribing Opioids Keeping Your Claimants Safe Presented by: Dr. Mitch Freeman, Pharm.D. Chief Clinical Officer, Pharmacy Solutions Agenda The Opioid Challenge Today How We Got Here

More information

Changing Prescribing Practices In Dentistry

Changing Prescribing Practices In Dentistry Changing Prescribing Practices In Dentistry Paul J. Desjardins, D.M.D., Ph.D. Adjunct Clinical Professor, Rutgers School of Dental Medicine Visiting Professor, Tufts University, School of Dental Medicine

More information

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers CENTERS FOR MEDICARE & MEDICAID SERVICES New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers Background CMS understands the magnitude of the nation s opioid epidemic and

More information

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic

September 22, National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC Prescription Opioid Epidemic National Association of Attorneys General 1850 M Street, NW, 12 th Floor Washington, DC 20036 RE: Prescription Opioid Epidemic On behalf of America s Health Insurance Plans (AHIP), thank you for your leadership

More information

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists Background Opioid medications are effective at treating certain types of pain,

More information

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin

More information

Overview of ASHP Opioid Efforts

Overview of ASHP Opioid Efforts Overview of ASHP Opioid Efforts Deborah A Pasko, Pharm.D, MHA Director, Medication Safety & Quality Nicholas Gentile Director, State Grassroots Advocacy and Political Action Presenter My educational background

More information

Ontario s Narcotics Strategy

Ontario s Narcotics Strategy Ontario s Narcotics Strategy Ontario Public Drug Programs Ministry of Health and Long-Term Care January 31, 2012 Ontario Harm Reduction Distribution Program Conference 2012 1 Background The Need for Action

More information

Rule Governing the Prescribing of Opioids for Pain

Rule Governing the Prescribing of Opioids for Pain Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This

More information

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Safe Prescribing of Drugs with Potential for Misuse/Diversion College of Physicians and Surgeons of British Columbia Safe Prescribing of Drugs with Potential for Misuse/Diversion Preamble This document establishes both professional standards as well as guidelines

More information

Veteran s Integrative Pain (VIP) Center: A program for high risk patients on chronic opioids

Veteran s Integrative Pain (VIP) Center: A program for high risk patients on chronic opioids Veteran s Integrative Pain (VIP) Center: A program for high risk patients on chronic opioids Hunter Holmes McGuire VA Richmond, VA Maggie Roma ANP-BC Clinic Administrative Coordinator Objectives Acknowledge

More information

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN State Senator Alberta Darling A NATIONAL PROBLEM According to the 2014 National Survey on Drug Use and Health: 435,000 Americans have used heroin

More information

Federal and State Controlled Substance Laws and Guidelines. Good Medicine for Prescribers and Patients

Federal and State Controlled Substance Laws and Guidelines. Good Medicine for Prescribers and Patients Federal and State Controlled Substance Laws and Guidelines Good Medicine for Prescribers and Patients Tennessee Chapter of the American College of Physicians Nashville, Tennessee 28 October 2017 Disclosure

More information

Opioid Data for Local Governments in North Carolina

Opioid Data for Local Governments in North Carolina Opioid Data for Local Governments in North Carolina Mary Beth Cox, Stacy Taylor, and Adam Lovelady October 10, 2018 Speakers Adam Lovelady Associate Professor UNC School of Government Mary Beth Cox Substance

More information

2. Is this request for a preferred medication? Y N

2. Is this request for a preferred medication? Y N Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Opioids Long-Acting and Short-Acting (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review

More information

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health

More information